Immunogenicity of NY-ESO-1 cancer testis antigen in triple-negative breast cancer

被引：0
|
作者：
Ademuyiwa, Foluso Olabisi
Bshara, Wiam
Attwood, Kristopher
Edge, Stephen B.
Ambrosone, Christine B.
Morrison, Carl D.
Ritter, Gerd
Miliotto, Anthony
Gnjatic, Sacha
Odunsi, Kunle
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[2] Ludwig Inst Canc Res, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11563
引用
收藏
页数：1
相关论文
共 50 条
  • [41] High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer
    Tanja, Badovinac Crnjevic
    Giulio, Spagnoli
    Antonio, Juretic
    Jasminka, Jakic-Razumovic
    Paula, Podolski
    Nera, Saric
    MEDICAL ONCOLOGY, 2012, 29 (03) : 1586 - 1591
  • [42] Clinicopathological assessment of cancer/testis antigens NY-ESO-1 and MAGE-A4 in osteosarcoma
    Hashimoto, Kazuhiko
    Nishimura, Shunji
    Ito, Tomohiko
    Oka, Naohiro
    Kakinoki, Ryosuke
    Akagi, Masao
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2022, 66 (03):
  • [43] WT1, NY-ESO-1 AND PRAME EXPRESSION IN BREAST CANCER SUBTYPES
    Esposito, A.
    Bagnardi, V.
    Criscitiello, C.
    Gelao, L.
    Viale, G.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2014, 25 : 18 - 18
  • [44] The expression of NY-ESO-1, cancer specific antigen, in patients with hepatocellular carcinoma.
    Nakamura, S
    Nouso, K
    Taniyama, M
    Kobayasi, Y
    Nakatsukasa, H
    Uemura, M
    Sato, S
    Yumoto, E
    Yokoyama, J
    Tsuboi, S
    Higashi, T
    Tsuji, T
    HEPATOLOGY, 2001, 34 (04) : 180A - 180A
  • [45] Recombinant NY-ESO-1 cancer antigen: Production and purification under cGMP conditions
    Murphy, R
    Green, S
    Ritter, G
    Cohen, L
    Ryan, D
    Woods, W
    Rubira, M
    Cebon, J
    Davis, ID
    Sjolander, A
    Kypridis, A
    Kalnins, H
    McNamara, M
    Moloney, MB
    Ackland, J
    Cartwright, G
    Rood, J
    Dumsday, G
    Healey, K
    Maher, D
    Maraskovsky, E
    Chen, YT
    Hoffman, EW
    Old, LJ
    Scott, AM
    PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2005, 35 (02): : 119 - 134
  • [46] Protein and DNA-based vaccines with the NY-ESO-1 antigen in cancer patients
    Sharma, P
    Bajorin, DF
    Altorki, NK
    Nishikawa, H
    Old, LJ
    Gnjatic, S
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 659 - 659
  • [47] Public NY-ESO-1 specific TCRs as novel biomarkers for immune monitoring of NY-ESO-1 positive cancer patients
    Lu, Hailing
    Pollack, Seth
    Somaiah, Neeta
    Chawla, Sant
    Hwu, Patrick
    Vignali, Marissa
    Rytlewski, Julie
    Gnjatic, Sacha
    ter Meulen, Jan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [48] Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1
    Iura, Kunio
    Maekawa, Akira
    Kohashi, Kenichi
    Ishii, Takeaki
    Bekki, Hirofumi
    Otsuka, Hiroshi
    Yamada, Yuichi
    Yamamoto, Hidetaka
    Harimaya, Katsumi
    Iwamoto, Yukihide
    Oda, Yoshinao
    HUMAN PATHOLOGY, 2017, 61 : 130 - 139
  • [49] NY-ESO-1 is associated with an aggressive phenotype of ovarian cancer
    Szender, J. B.
    Papanicolau-Sengos, A.
    Eng, K.
    Miliotto, A. J.
    Lugade, A.
    Gnjatic, S.
    Matsuzaki, J.
    Odunsi, K.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 30 - 30
  • [50] The role of a cancer testis-antigen in regulating tumor growth and oncogenic pathways in triple-negative breast cancer
    Sedano, Melina J.
    Harrison, Alana L.
    Le, Ine
    Gadad, Shrikanth S.
    CANCER RESEARCH, 2022, 82 (04)
12345